(19)
(11) EP 0 662 831 A1

(12)

(43) Date of publication:
19.07.1995 Bulletin 1995/29

(21) Application number: 93921210.0

(22) Date of filing: 02.09.1993
(51) International Patent Classification (IPC): 
C07D 409/ 06( . )
A61K 31/ 40( . )
A61K 31/ 405( . )
A61P 25/ 04( . )
A61K 9/ 48( . )
A61K 31/ 4045( . )
A61K 47/ 14( . )
A61P 29/ 00( . )
(86) International application number:
PCT/US1993/008063
(87) International publication number:
WO 1994/007488 (14.04.1994 Gazette 1994/09)
(84) Designated Contracting States:
AT BE CH DE DK FR GB GR IE IT LI LU NL PT SE

(30) Priority: 07.10.1992 US 19920957930

(71) Applicant: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventor:
  • AHMED, Imran
    Gales Ferry, CT 06335 (US)

(74) Representative: Moore, James William, Dr., et al 
Pfizer Limited Ramsgate Road
Sandwich Kent CT13 9NJ
Sandwich Kent CT13 9NJ (GB)

   


(54) 3-SUBSTITUTED 2-OXINDOLE-1-CARBOXAMIDE PHARMACEUTICAL COMPOSITIONS